Citations Report
Clinical Schizophrenia & Related Psychoses : Citations & Metrics Report
Articles published in Clinical Schizophrenia & Related Psychoses have been cited by esteemed scholars and scientists all around the world. Clinical Schizophrenia & Related Psychoses has got h-index 41, which means every article in Clinical Schizophrenia & Related Psychoses has got 41 average citations.
Following are the list of articles that have cited the articles published in Clinical Schizophrenia & Related Psychoses.
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Year wise published articles |
105 | 141 | 28 | 8 | 28 |
Year wise citations received |
543 | 553 | 590 | 563 | 587 |
| Journal total citations count | 6601 |
| Journal Impact Factor | 6.49 |
| Journal 5 years Impact Factor | 12.17 |
| Journal CiteScore | 11.19 |
| Journal h-index | 41 |
| Journal h-index since 2016 | 26 |
Gerken, Adrienne T., Shunda McGahee, Alex S. Keuroghlian, and Oliver Freudenreich. "CLINICAL CHALLENGE." (2016). |
|
Krzystanek, Marek, Marek Asman, Joanna Witecka, Artur Pa?asz, and Ryszard Wiaderkiewicz. "Selected single-nucleotide variants in GRIN1, GRIN2A, and GRIN2B encoding subunits of the NMDA receptor are not biomarkers of schizophrenia resistant to clozapine: exploratory study." Pharmacological Reports 73, no. 1 (2021): 309-315. |
|
Gerken, Adrienne T., Shunda McGahee, Alex S. Keuroghlian, and Oliver Freudenreich. "Consideration of clozapine and gender-affirming medical care for an HIV-positive person with schizophrenia and fluctuating gender identity." Harvard review of psychiatry 24, no. 6 (2016): 406-415. |
|
Krzystanek, Marek, Marek Asman, Joanna Witecka, Artur Pa?asz, and Ryszard Wiaderkiewicz. "Exploratory study of selected nucleotide variants in GRIN1, GRIN2A and GRIN2B encoding subunits of the NMDA receptor in a targeted group of schizophrenia patients with chronic cognitive impairment." Pharmacological Reports 73, no. 1 (2021): 269-277. |
|
Silva, Edward, Melanie Higgins, Barbara Hammer, and Paul Stephenson. "Clozapine rechallenge and initiation despite neutropenia-a practical, step-by-step guide." BMC psychiatry 20 (2020): 1-9. |
|
Steffens, Maria. "Cognition and Oculomotor Control in Model Systems of Psychosis." (2020). |
|
Andrade, Chittaranjan. "Transcranial direct current stimulation for refractory auditory hallucinations in schizophrenia." The Journal of clinical psychiatry 74, no. 11 (2013): 0-0. |
|
Zink, Mathias, and Christoph U. Correll. "Glutamatergic agents for schizophrenia: current evidence and perspectives." Expert review of clinical pharmacology 8, no. 3 (2015): 335-352. |
|
Aydin, Memduha, Bilge Cetin Ilhan, Saliha Calisir, Seda Yildirim, and Ibrahim Eren. "Continuing clozapine treatment with lithium in schizophrenic patients with neutropenia or leukopenia: brief review of literature with case reports." Therapeutic advances in psychopharmacology 6, no. 1 (2016): 33-38. |
|
Gallant, Stephanie. "Neurodevelopmental animal models of schizophrenia-like behaviours: Behavioural and neurochemical consequences of maternal immune challenge and prenatal NMDA receptor blockade." PhD diss., Concordia University, 2014. |
|
Correll, Christoph U., Lawrence Maayan, John Kane, Marc De Hert, and Dan Cohen. "Efficacy for psychopathology and body weight and safety of topiramate-antipsychotic cotreatment in patients with schizophrenia spectrum disorders: results from a meta-analysis of randomized controlled trials." The Journal of clinical psychiatry 77, no. 6 (2016): 0-0. |
|
Svane, Kirsten. "Nitric oxide synthase 1 adaptor protein as a target for treatment of schizophrenia." PhD diss., Rutgers University-School of Graduate Studies, 2018. |
|
Zheng, W., Y?T. Xiang, Y?Q. Xiang, X?B. Li, G. S. Ungvari, H. F. K. Chiu, and C. U. Correll. "Efficacy and safety of adjunctive topiramate for schizophrenia: a meta?analysis of randomized controlled trials." Acta Psychiatrica Scandinavica 134, no. 5 (2016): 385-398. |
|
Sivashanker, Karthik. "Early Intervention for Schizophrenia, Part 2: A Review." Early Intervention for Schizophrenia, Part 2: A Review Karthik Sivashanker, MD (2011): 1. |
|
Aryutova, Katrin, and Drozdstoy Stoyanov. "Pharmaco-Magnetic Resonance as a Tool for Monitoring the Medication-Related Effects in the Brain May Provide Potential Biomarkers for Psychotic Disorders." International Journal of Molecular Sciences 22, no. 17 (2021): 9309. |
|
Madularu, Dan. "Advancing rodent models of the behaviours and the neurobiological pathology associated with schizophrenia." PhD diss., Concordia University, 2014. |
|
Ptak, Carolyn. "Genetic-epigenetic Interactions: Sequence-dependent and Independent DNA Nethylation." PhD diss., 2013. |
|
Atallah-Yunes, Suheil Albert, Audrey Ready, and Peter E. Newburger. "Benign ethnic neutropenia." Blood reviews 37 (2019): 100586. |
|
Alberati, Daniela, Judith Lengyel, Nicole Hauser, and Roland Mory. "Glycine reuptake inhibitor RG1678: A pharmacologic characterization of an investigational agent for the treatmen..." |
|
Krzystanek, M. A. R. E. K., P. A. W. E. ?. Krzywda, A. D. A. M. Klasik, and I. R. E. N. A. Krupka-Matuszczyk. "Treningi kognitywne jako nowa forma terapii w schizofrenii." Post?py Psychiatrii i Neurologii 22, no. 3 (2013): 193-199. |
|